192 related articles for article (PubMed ID: 22613403)
21. Modulation of multidrug resistance in cancer cells by the E3 ubiquitin ligase seven-in-absentia homologue 1.
Liu M; Aneja R; Wang H; Sun L; Dong X; Huo L; Joshi H; Zhou J
J Pathol; 2008 Mar; 214(4):508-14. PubMed ID: 18213731
[TBL] [Abstract][Full Text] [Related]
22. New insight into p-glycoprotein as a drug target.
Breier A; Gibalova L; Seres M; Barancik M; Sulova Z
Anticancer Agents Med Chem; 2013 Jan; 13(1):159-70. PubMed ID: 22931413
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms of multidrug resistance in cancer chemotherapy.
Nooter K; Stoter G
Pathol Res Pract; 1996 Jul; 192(7):768-80. PubMed ID: 8880878
[TBL] [Abstract][Full Text] [Related]
24. Opposing roles of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in the cellular response to ionizing radiation in human cervical cancer cells.
Kim MJ; Choi SY; Park IC; Hwang SG; Kim C; Choi YH; Kim H; Lee KH; Lee SJ
Mol Cancer Res; 2008 Nov; 6(11):1718-31. PubMed ID: 19010820
[TBL] [Abstract][Full Text] [Related]
25. Antitumour effect and modulation of expression of the ABCB1 gene by perifosine in canine lymphoid tumour cell lines.
Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
Vet J; 2014 Jul; 201(1):83-90. PubMed ID: 24881508
[TBL] [Abstract][Full Text] [Related]
26. Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition.
Yun UJ; Lee JH; Koo KH; Ye SK; Kim SY; Lee CH; Kim YN
Biochem Pharmacol; 2013 May; 85(10):1441-53. PubMed ID: 23473805
[TBL] [Abstract][Full Text] [Related]
27. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
Kaye SB
Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells.
Saatian B; Zhao Y; He D; Georas SN; Watkins T; Spannhake EW; Natarajan V
Biochem J; 2006 Feb; 393(Pt 3):657-68. PubMed ID: 16197369
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein-E controls adenosine triphosphate-binding cassette transporters ABCB1 and ABCC1 on cerebral microvessels after methamphetamine intoxication.
ElAli A; Urrutia A; Rubio-Araiz A; Hernandez-Jimenez M; Colado MI; Doeppner TR; Hermann DM
Stroke; 2012 Jun; 43(6):1647-53. PubMed ID: 22426312
[TBL] [Abstract][Full Text] [Related]
30. Can long range mechanical interaction between drugs and membrane proteins define the notion of molecular promiscuity? Application to P-glycoprotein-mediated multidrug resistance (MDR).
Rauch C; Paine SW; Littlewood P
Biochim Biophys Acta; 2013 Nov; 1830(11):5112-8. PubMed ID: 23850561
[TBL] [Abstract][Full Text] [Related]
31. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
32. Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?
Rovida E; Stecca B
Semin Cancer Biol; 2015 Dec; 35():154-67. PubMed ID: 26292171
[TBL] [Abstract][Full Text] [Related]
33. Adenosine A2A receptor occupancy stimulates collagen expression by hepatic stellate cells via pathways involving protein kinase A, Src, and extracellular signal-regulated kinases 1/2 signaling cascade or p38 mitogen-activated protein kinase signaling pathway.
Che J; Chan ES; Cronstein BN
Mol Pharmacol; 2007 Dec; 72(6):1626-36. PubMed ID: 17872970
[TBL] [Abstract][Full Text] [Related]
34. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance.
Brozovic A; Fritz G; Christmann M; Zisowsky J; Jaehde U; Osmak M; Kaina B
Int J Cancer; 2004 Dec; 112(6):974-85. PubMed ID: 15386344
[TBL] [Abstract][Full Text] [Related]
35. (+/-)-3'-O, 4'-O-dicynnamoyl-cis-khellactone, a derivative of (+/-)-praeruptorin A, reverses P-glycoprotein mediated multidrug resistance in cancer cells.
Shen X; Chen G; Zhu G; Fong WF
Bioorg Med Chem; 2006 Nov; 14(21):7138-45. PubMed ID: 16875827
[TBL] [Abstract][Full Text] [Related]
36. Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function.
Elamanchili P; McEachern C; Burt H
J Pharm Sci; 2009 Mar; 98(3):945-58. PubMed ID: 18623213
[TBL] [Abstract][Full Text] [Related]
37. JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells.
Yan F; Wang XM; Liu ZC; Pan C; Yuan SB; Ma QM
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):287-95. PubMed ID: 20525557
[TBL] [Abstract][Full Text] [Related]
38. Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells.
Kopecka J; Campia I; Jacobs A; Frei AP; Ghigo D; Wollscheid B; Riganti C
Oncotarget; 2015 Mar; 6(9):6776-93. PubMed ID: 25686827
[TBL] [Abstract][Full Text] [Related]
39. Gene Therapeutic Approaches to Overcome ABCB1-Mediated Drug Resistance.
Lage H
Recent Results Cancer Res; 2016; 209():87-94. PubMed ID: 28101689
[TBL] [Abstract][Full Text] [Related]
40. MG‑132 reverses multidrug resistance by activating the JNK signaling pathway in FaDu/T cells.
Ma J; Lv Z; Liu X; Liu X; Xu W
Mol Med Rep; 2018 Aug; 18(2):1820-1825. PubMed ID: 29901180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
